It’s called SenSight * and it’s an anti-Parkinson’s ‘pacemaker’, a directional lead system developed by Medtronic for Deep Brain Stimulation (Dbs) therapy. “A directional stimulation that allows you to customize the therapy, and to provide individual and patient-specific data thanks to the sensing function for detecting brain signals”: these, explains the company, are the innovative features of the new device, used together with the neurostimulator. Percept * PC introduced to the market last year.
Read Also
- Love is in the Air, previews today 3 September: Eda against Balca Sep 3, 2021
- Tinder: The app launches “useful screenshots” against gender-based and sexual violence Nov 24, 2022
- Sharp drop in soy prices: more than US $ 20 fell in Chicago Aug 30, 2021
- Expiration Flexibility and Extension: Dealing With Pandemic Air Miles Sep 8, 2021
- A Paraguayan prosecutor dismissed a complaint by Chilavert against Alejandro Domínguez May 25, 2022
- “I’m worried about his mental health”: Maryfer Centeno analyzed Nodal’s lawsuit against J Balvin Jun 3, 2022
- Experts encourage Dominican merchants to use Amazon to commodify products May 5, 2022